Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Disclosure needed

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jan 28, 2021 7:38pm

159 Views

Post# 32416263

RE:Disclosure needed

I disclose that I am simply long and have no connections in any shape or form with ThTx employees management supplier or any one connected with THTX

palinc2000 wrote: The posters on this MB are anonymous and I have no problem with that ,BUT I think that posters should reveal any connections with THTX other than being a long or a short,I find it indecent that a poster would not disclose a relationship with THTX by way of sighnificant partner ,family member or any other similar relationship ,,,,,,Of course nobody in this MB fits that description

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project